nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—ABCB1—Allograft Rejection—CXCL11—nasal cavity cancer	0.0255	0.0255	CbGpPWpGaD
Fluphenazine—DRD3—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0225	0.0225	CbGpPWpGaD
Fluphenazine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.021	0.021	CbGpPWpGaD
Fluphenazine—HTR1A—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0196	0.0196	CbGpPWpGaD
Fluphenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0181	0.0181	CbGpPWpGaD
Fluphenazine—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0179	0.0179	CbGpPWpGaD
Fluphenazine—DRD2—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0172	0.0172	CbGpPWpGaD
Fluphenazine—HTR6—GPCR ligand binding—CXCL11—nasal cavity cancer	0.016	0.016	CbGpPWpGaD
Fluphenazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0156	0.0156	CbGpPWpGaD
Fluphenazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0155	0.0155	CbGpPWpGaD
Fluphenazine—ADRA2A—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0154	0.0154	CbGpPWpGaD
Fluphenazine—DRD1—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0138	0.0138	CbGpPWpGaD
Fluphenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0137	0.0137	CbGpPWpGaD
Fluphenazine—DRD3—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0136	0.0136	CbGpPWpGaD
Fluphenazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0135	0.0135	CbGpPWpGaD
Fluphenazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0134	0.0134	CbGpPWpGaD
Fluphenazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0122	0.0122	CbGpPWpGaD
Fluphenazine—CALM3—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0119	0.0119	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0119	0.0119	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Fluphenazine—CALM1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0115	0.0115	CbGpPWpGaD
Fluphenazine—CALM2—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0115	0.0115	CbGpPWpGaD
Fluphenazine—CALM3—Downstream signal transduction—FRS2—nasal cavity cancer	0.0112	0.0112	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by FGFR—FRS2—nasal cavity cancer	0.0111	0.0111	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0111	0.0111	CbGpPWpGaD
Fluphenazine—CALM3—DAP12 signaling—FRS2—nasal cavity cancer	0.011	0.011	CbGpPWpGaD
Fluphenazine—CALM2—Downstream signal transduction—FRS2—nasal cavity cancer	0.0108	0.0108	CbGpPWpGaD
Fluphenazine—CALM1—Downstream signal transduction—FRS2—nasal cavity cancer	0.0108	0.0108	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by FGFR—FRS2—nasal cavity cancer	0.0108	0.0108	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by FGFR—FRS2—nasal cavity cancer	0.0108	0.0108	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Fluphenazine—CALM2—DAP12 signaling—FRS2—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Fluphenazine—CALM1—DAP12 signaling—FRS2—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Fluphenazine—DRD2—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Fluphenazine—CALM3—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Fluphenazine—CALM3—DAP12 interactions—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by EGFR—FRS2—nasal cavity cancer	0.0103	0.0103	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Fluphenazine—HRH1—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by PDGF—FRS2—nasal cavity cancer	0.0102	0.0102	CbGpPWpGaD
Fluphenazine—CALM2—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.01	0.01	CbGpPWpGaD
Fluphenazine—CALM1—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.01	0.01	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.01	0.01	CbGpPWpGaD
Fluphenazine—CALM2—DAP12 interactions—FRS2—nasal cavity cancer	0.01	0.01	CbGpPWpGaD
Fluphenazine—CALM1—DAP12 interactions—FRS2—nasal cavity cancer	0.01	0.01	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.01	0.01	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR—FRS2—nasal cavity cancer	0.00996	0.00996	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR—FRS2—nasal cavity cancer	0.00996	0.00996	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00987	0.00987	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00987	0.00987	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by PDGF—FRS2—nasal cavity cancer	0.00983	0.00983	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by PDGF—FRS2—nasal cavity cancer	0.00983	0.00983	CbGpPWpGaD
Fluphenazine—CALM3—B Cell Activation—FRS2—nasal cavity cancer	0.00961	0.00961	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00932	0.00932	CbGpPWpGaD
Fluphenazine—CALM2—B Cell Activation—FRS2—nasal cavity cancer	0.0093	0.0093	CbGpPWpGaD
Fluphenazine—CALM1—B Cell Activation—FRS2—nasal cavity cancer	0.0093	0.0093	CbGpPWpGaD
Fluphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0092	0.0092	CbGpPWpGaD
Fluphenazine—HTR6—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00905	0.00905	CbGpPWpGaD
Fluphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0089	0.0089	CbGpPWpGaD
Fluphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0089	0.0089	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00822	0.00822	CbGpPWpGaD
Fluphenazine—DRD1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00779	0.00779	CbGpPWpGaD
Fluphenazine—DRD3—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00769	0.00769	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00708	0.00708	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—FRS2—nasal cavity cancer	0.00708	0.00708	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00698	0.00698	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—FRS2—nasal cavity cancer	0.00684	0.00684	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—FRS2—nasal cavity cancer	0.00684	0.00684	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.0067	0.0067	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00667	0.00667	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00609	0.00609	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00605	0.00605	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00588	0.00588	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00579	0.00579	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00578	0.00578	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00534	0.00534	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00527	0.00527	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00526	0.00526	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00525	0.00525	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CXCL11—nasal cavity cancer	0.00486	0.00486	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00478	0.00478	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00436	0.00436	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00422	0.00422	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00422	0.00422	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00418	0.00418	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00413	0.00413	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—FRS2—nasal cavity cancer	0.00404	0.00404	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—FRS2—nasal cavity cancer	0.0039	0.0039	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—FRS2—nasal cavity cancer	0.0039	0.0039	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—FRS2—nasal cavity cancer	0.00388	0.00388	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—FRS2—nasal cavity cancer	0.00375	0.00375	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—FRS2—nasal cavity cancer	0.00375	0.00375	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CXCL11—nasal cavity cancer	0.0036	0.0036	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CXCL11—nasal cavity cancer	0.00358	0.00358	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00316	0.00316	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00311	0.00311	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CXCL11—nasal cavity cancer	0.0031	0.0031	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—FRS2—nasal cavity cancer	0.00286	0.00286	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00283	0.00283	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00258	0.00258	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00249	0.00249	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00249	0.00249	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—FRS2—nasal cavity cancer	0.00246	0.00246	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—FRS2—nasal cavity cancer	0.00243	0.00243	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—FRS2—nasal cavity cancer	0.00235	0.00235	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—FRS2—nasal cavity cancer	0.00227	0.00227	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—FRS2—nasal cavity cancer	0.00227	0.00227	CbGpPWpGaD
Fluphenazine—CALM3—Disease—FRS2—nasal cavity cancer	0.00217	0.00217	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—FRS2—nasal cavity cancer	0.00212	0.00212	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—FRS2—nasal cavity cancer	0.00211	0.00211	CbGpPWpGaD
Fluphenazine—CALM1—Disease—FRS2—nasal cavity cancer	0.0021	0.0021	CbGpPWpGaD
Fluphenazine—CALM2—Disease—FRS2—nasal cavity cancer	0.0021	0.0021	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—FRS2—nasal cavity cancer	0.00186	0.00186	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—FRS2—nasal cavity cancer	0.00183	0.00183	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—FRS2—nasal cavity cancer	0.00183	0.00183	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—FRS2—nasal cavity cancer	0.00167	0.00167	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—FRS2—nasal cavity cancer	0.00152	0.00152	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—FRS2—nasal cavity cancer	0.00147	0.00147	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—FRS2—nasal cavity cancer	0.00147	0.00147	CbGpPWpGaD
